How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Thousands of low-income New Yorkers are among the first to feel the impacts of the "Big Beautiful Bill." by Alana Semuels by Philip Elliott Allison Robbert—The Washington Post/Getty Images) by Connor ...

The definitive, minute-by-minute guide to every billionaire around the globe. See who's up, who's down and who's a new member of the three-comma club.